术后复发性肝癌外科治疗的现状及进展  

Status and progress of surgical treatment of postoperative recurrent hepatocellular carcinoma

作　　者：胡瀚 吴德全[1] HU Han;WU Dequan(Department of Liver Surgery,The Second Affiliated Hospital of Harbin Medical University,Harbin 150001,P.R.China)

机构地区：[1]哈尔滨医科大学附属第二医院肝脏外科,哈尔滨150001

出　　处：《中国普外基础与临床杂志》2021年第4期551-555,共5页Chinese Journal of Bases and Clinics In General Surgery

摘　　要：目的总结术后复发性肝癌外科治疗的现状及进展。方法查阅近年来有关术后复发性肝癌外科治疗的相关文献并进行综述。结果外科手术是治疗复发性肝癌的有效手段,其手术方式分为再次肝切除和挽救性肝移植。再次肝切除的手术适应证尚无统一标准,但基本原则一致,而挽救性肝移植的适应证目前主要依据Milan标准。对于符合手术适应证的复发性肝癌患者,外科手术可提高患者远期生存率,使患者获益。结论采用外科手术治疗复发性肝癌,应结合患者的手术适应证、初次肝切除时的肿瘤情况、术后复发时间等因素选择合适的患者及合理的手术方式积极进行治疗,可延长患者生存时间、提高患者远期生存率。Objective To summarize the current status and progress of surgical treatment for postoperative recurrent hepatocellular carcinoma(HCC).Method The literatures about studies of surgical treatment of postoperative recurrent HCC were reviewed.Results The surgical operation was an effective method for the treatment of recurrent HCC.The operation methods included re-hepatectomy and salvage liver transplantation.There was no uniform standard for the indication of re-hepatectomy,but the basic principles were the same.At present,the indication of salvage liver transplantation was mainly based on Milan criteria.For patients with recurrent HCC who met the operation indications,surgical operation could improve the long-term survival rate of patients and benefit the patients.Conclusion It migh prolong the survival time and improve the long-term survival rate of patients with recurrent HCC when the appropriate patients and reasonable surgical methods are chosen according to the surgical indications,the tumor situation of initial hepatectomy,postoperative recurrence time,and other factors.

关 键 词：复发性肝细胞癌 再次肝切除 挽救性肝移植 

分 类 号：R735.7[医药卫生—肿瘤]